Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 105

Results For "NTU"

1059 News Found

Govt. to give 12 Cr COVID vaccine doses in June 2021
News | May 31, 2021

Govt. to give 12 Cr COVID vaccine doses in June 2021

7.94 crore doses were made available to the states in May 2021


Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21
News | May 27, 2021

Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21

Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21


Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma
News | May 25, 2021

Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma

The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr


Lincoln consolidated Q4FY21 net profit at Rs. 12.57 Cr
News | May 25, 2021

Lincoln consolidated Q4FY21 net profit at Rs. 12.57 Cr

The company plans to enter the EU markets in FY22


India's first indigenous COVID-19 RT-PCR testing kit approved
News | May 21, 2021

India's first indigenous COVID-19 RT-PCR testing kit approved

This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips


Outlook intact for Dr. Reddy's Laboratories : ICICI Securities
News | May 18, 2021

Outlook intact for Dr. Reddy's Laboratories : ICICI Securities

India sales grew 23.5% YoY with consolidation of Wockhardt products


Govt. to supply 1.92 crore COVID vaccines during May 16-31
News | May 16, 2021

Govt. to supply 1.92 crore COVID vaccines during May 16-31

A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021


CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating
News | May 11, 2021

CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating

The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.


Biosimilars performance below expectations for Biocon : ICICI Direct
Biotech | May 03, 2021

Biosimilars performance below expectations for Biocon : ICICI Direct

The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.


Govt. approves 25 manufacturing sites for Remdesivir production
News | April 26, 2021

Govt. approves 25 manufacturing sites for Remdesivir production

The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month